Heterogeneous brain FDG-PET metabolic patterns in patients with C9orf72 mutation

Zurück zum Zitat Renton AE, Majounie E, Waite A, Simón-Sánchez J, Rollinson S, Gibbs JR, Schymick JC, Laaksovirta H, van Swieten J, Myllykangas L, Kalimo H, Paetau A, Abramzon Y, Remes AM, Kaganovich A, Scholz SW, Duckworth J, Ding J, Harmer DW, Hernandez DG, Johnson JO, Mok K, Ryten M, Trabzuni D, Guerreiro RJ, Orrell RW, Neal J, Murray A, Pearson J, Jansen IE, Sondervan D, Seelaar H, Blake D, Young K, Halliwell N, Callister JB, Toulson G, Richardson A, Gerhard A, Snowden J, Mann D, Neary D, Nalls MA, Peuralinna T, Jansson L, Isoviita VM, Kaivorinne AL, Hölttä-Vuori M, Ikonen E, Sulkava R, Benatar M, Wuu J, Chiò A, Restagno G, Borghero G, Sabatelli M, ITALSGEN Consortium, Heckerman D, Rogaeva E, Zinman L, Rothstein JD, Sendtner M, Drepper C, Eichler EE, Alkan C, Abdullaev Z, Pack SD, Dutra A, Pak E, Hardy J, Singleton A, Williams NM, Heutink P, Pickering-Brown S, Morris HR, Tienari PJ, Traynor BJ (2011) A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72:257–268. https://doi.org/10.1016/j.neuron.2011.09.010 CrossRefPubMedPubMedCentral Renton AE, Majounie E, Waite A, Simón-Sánchez J, Rollinson S, Gibbs JR, Schymick JC, Laaksovirta H, van Swieten J, Myllykangas L, Kalimo H, Paetau A, Abramzon Y, Remes AM, Kaganovich A, Scholz SW, Duckworth J, Ding J, Harmer DW, Hernandez DG, Johnson JO, Mok K, Ryten M, Trabzuni D, Guerreiro RJ, Orrell RW, Neal J, Murray A, Pearson J, Jansen IE, Sondervan D, Seelaar H, Blake D, Young K, Halliwell N, Callister JB, Toulson G, Richardson A, Gerhard A, Snowden J, Mann D, Neary D, Nalls MA, Peuralinna T, Jansson L, Isoviita VM, Kaivorinne AL, Hölttä-Vuori M, Ikonen E, Sulkava R, Benatar M, Wuu J, Chiò A, Restagno G, Borghero G, Sabatelli M, ITALSGEN Consortium, Heckerman D, Rogaeva E, Zinman L, Rothstein JD, Sendtner M, Drepper C, Eichler EE, Alkan C, Abdullaev Z, Pack SD, Dutra A, Pak E, Hardy J, Singleton A, Williams NM, Heutink P, Pickering-Brown S, Morris HR, Tienari PJ, Traynor BJ (2011) A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72:257–268. https://​doi.​org/​10.​1016/​j.​neuron.​2011.​09.​010 CrossRefPubMedPubMedCentral

Zurück zum Zitat DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, Nicholson AM, Finch NCA, Flynn H, Adamson J, Kouri N, Wojtas A, Sengdy P, Hsiung GYR, Karydas A, Seeley WW, Josephs KA, Coppola G, Geschwind DH, Wszolek ZK, Feldman H, Knopman DS, Petersen RC, Miller BL, Dickson DW, Boylan KB, Graff-Radford NR, Rademakers R (2011) Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72:245–256. https://doi.org/10.1016/j.neuron.2011.09.011 CrossRefPubMedPubMedCentral DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, Nicholson AM, Finch NCA, Flynn H, Adamson J, Kouri N, Wojtas A, Sengdy P, Hsiung GYR, Karydas A, Seeley WW, Josephs KA, Coppola G, Geschwind DH, Wszolek ZK, Feldman H, Knopman DS, Petersen RC, Miller BL, Dickson DW, Boylan KB, Graff-Radford NR, Rademakers R (2011) Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72:245–256. https://​doi.​org/​10.​1016/​j.​neuron.​2011.​09.​011 CrossRefPubMedPubMedCentral

Zurück zum Zitat Yokoyama JS, Sirkis DW, Miller BL (2014) C9ORF72 hexanucleotide repeats in behavioral and motor neuron disease: clinical heterogeneity and pathological diversity. Am J Neurodegener Dis 3:1–18PubMedPubMedCentral Yokoyama JS, Sirkis DW, Miller BL (2014) C9ORF72 hexanucleotide repeats in behavioral and motor neuron disease: clinical heterogeneity and pathological diversity. Am J Neurodegener Dis 3:1–18PubMedPubMedCentral

Zurück zum Zitat Cruts M, Gijselinck I, Van Langenhove T et al (2013) Current insights into the C9orf72 repeat expansion diseases of the FTLD/ALS spectrum. Trends Neurosci 36:450–459. https://doi.org/10.1016/j.tins.2013.04.010 CrossRefPubMed Cruts M, Gijselinck I, Van Langenhove T et al (2013) Current insights into the C9orf72 repeat expansion diseases of the FTLD/ALS spectrum. Trends Neurosci 36:450–459. https://​doi.​org/​10.​1016/​j.​tins.​2013.​04.​010 CrossRefPubMed

Zurück zum Zitat Haeusler AR, Donnelly CJ, Periz G et al (2014) C9orf72 nucleotide repeat structures initiate molecular cascades of disease. Nature 507:1–20. https://doi.org/10.1038/nature13124.C9orf72 CrossRef Haeusler AR, Donnelly CJ, Periz G et al (2014) C9orf72 nucleotide repeat structures initiate molecular cascades of disease. Nature 507:1–20. https://​doi.​org/​10.​1038/​nature13124.​C9orf72 CrossRef

Zurück zum Zitat Couratier P, Corcia P, Lautrette G, Nicol M, Marin B (2017) ALS and frontotemporal dementia belong to a common disease spectrum. Rev Neurol (Paris) 173:273–279CrossRef Couratier P, Corcia P, Lautrette G, Nicol M, Marin B (2017) ALS and frontotemporal dementia belong to a common disease spectrum. Rev Neurol (Paris) 173:273–279CrossRef

Zurück zum Zitat Silani V, Ludolph A, Fornai F (2017) The emerging picture of ALS: a multisystem, not only a “motor neuron disease.”. In: Arch Ital Biol Silani V, Ludolph A, Fornai F (2017) The emerging picture of ALS: a multisystem, not only a “motor neuron disease.”. In: Arch Ital Biol

Zurück zum Zitat Boeve BF, Boylan KB, Graff-Radford NR, DeJesus-Hernandez M, Knopman DS, Pedraza O, Vemuri P, Jones D, Lowe V, Murray ME, Dickson DW, Josephs KA, Rush BK, Machulda MM, Fields JA, Ferman TJ, Baker M, Rutherford NJ, Adamson J, Wszolek ZK, Adeli A, Savica R, Boot B, Kuntz KM, Gavrilova R, Reeves A, Whitwell J, Kantarci K, Jack CR Jr, Parisi JE, Lucas JA, Petersen RC, Rademakers R (2012) Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72. Brain 135:765–783. https://doi.org/10.1093/brain/aws004 CrossRefPubMedPubMedCentral Boeve BF, Boylan KB, Graff-Radford NR, DeJesus-Hernandez M, Knopman DS, Pedraza O, Vemuri P, Jones D, Lowe V, Murray ME, Dickson DW, Josephs KA, Rush BK, Machulda MM, Fields JA, Ferman TJ, Baker M, Rutherford NJ, Adamson J, Wszolek ZK, Adeli A, Savica R, Boot B, Kuntz KM, Gavrilova R, Reeves A, Whitwell J, Kantarci K, Jack CR Jr, Parisi JE, Lucas JA, Petersen RC, Rademakers R (2012) Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72. Brain 135:765–783. https://​doi.​org/​10.​1093/​brain/​aws004 CrossRefPubMedPubMedCentral

Zurück zum Zitat Cistaro A, Pagani M, Montuschi A, Calvo A, Moglia C, Canosa A, Restagno G, Brunetti M, Traynor BJ, Nobili F, Carrara G, Fania P, Lopiano L, Valentini MC, Chiò A (2014) The metabolic signature of C9ORF72-related ALS: FDG PET comparison with nonmutated patients. Eur J Nucl Med Mol Imaging 41:844–852. https://doi.org/10.1007/s00259-013-2667-5 CrossRefPubMed Cistaro A, Pagani M, Montuschi A, Calvo A, Moglia C, Canosa A, Restagno G, Brunetti M, Traynor BJ, Nobili F, Carrara G, Fania P, Lopiano L, Valentini MC, Chiò A (2014) The metabolic signature of C9ORF72-related ALS: FDG PET comparison with nonmutated patients. Eur J Nucl Med Mol Imaging 41:844–852. https://​doi.​org/​10.​1007/​s00259-013-2667-5 CrossRefPubMed

Zurück zum Zitat Van Laere K, Vanhee A, Verschueren J et al (2014) Value of 18Fluorodeoxyglucose–positron-emission tomography in amyotrophic lateral sclerosis: a prospective study. JAMA Neurol 71:553–561CrossRefPubMed Van Laere K, Vanhee A, Verschueren J et al (2014) Value of 18Fluorodeoxyglucose–positron-emission tomography in amyotrophic lateral sclerosis: a prospective study. JAMA Neurol 71:553–561CrossRefPubMed

Zurück zum Zitat Devenney E, Hornberger M, Irish M, Mioshi E, Burrell J, Tan R, Kiernan MC, Hodges JR (2014) Frontotemporal dementia associated with the C9ORF72 mutation: a unique clinical profile. JAMA Neurol 71:331–339. https://doi.org/10.1001/jamaneurol.2013.6002 CrossRefPubMed Devenney E, Hornberger M, Irish M, Mioshi E, Burrell J, Tan R, Kiernan MC, Hodges JR (2014) Frontotemporal dementia associated with the C9ORF72 mutation: a unique clinical profile. JAMA Neurol 71:331–339. https://​doi.​org/​10.​1001/​jamaneurol.​2013.​6002 CrossRefPubMed

Zurück zum Zitat Perani D, Della Rosa PA, Cerami C, Gallivanone F, Fallanca F, Vanoli EG, Panzacchi A, Nobili F, Pappatà S, Marcone A, Garibotto V, Castiglioni I, Magnani G, Cappa SF, Gianolli L, EADC-PET Consortium (2014) Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical setting. NeuroImage Clin 6:445–454. https://doi.org/10.1016/j.nicl.2014.10.009 CrossRefPubMedPubMedCentral Perani D, Della Rosa PA, Cerami C, Gallivanone F, Fallanca F, Vanoli EG, Panzacchi A, Nobili F, Pappatà S, Marcone A, Garibotto V, Castiglioni I, Magnani G, Cappa SF, Gianolli L, EADC-PET Consortium (2014) Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical setting. NeuroImage Clin 6:445–454. https://​doi.​org/​10.​1016/​j.​nicl.​2014.​10.​009 CrossRefPubMedPubMedCentral

Zurück zum Zitat Perani D, Cerami C, Caminiti SP, Santangelo R, Coppi E, Ferrari L, Pinto P, Passerini G, Falini A, Iannaccone S, Cappa SF, Comi G, Gianolli L, Magnani G (2016) Cross-validation of biomarkers for the early differential diagnosis and prognosis of dementia in a clinical setting. Eur J Nucl Med Mol Imaging 43:499–508. https://doi.org/10.1007/s00259-015-3170-y CrossRefPubMed Perani D, Cerami C, Caminiti SP, Santangelo R, Coppi E, Ferrari L, Pinto P, Passerini G, Falini A, Iannaccone S, Cappa SF, Comi G, Gianolli L, Magnani G (2016) Cross-validation of biomarkers for the early differential diagnosis and prognosis of dementia in a clinical setting. Eur J Nucl Med Mol Imaging 43:499–508. https://​doi.​org/​10.​1007/​s00259-015-3170-y CrossRefPubMed

Zurück zum Zitat Cerami C, Della Rosa PA, Magnani G, Santangelo R, Marcone A, Cappa SF, Perani D (2015) Brain metabolic maps in mild cognitive impairment predict heterogeneity of progression to dementia. NeuroImage Clin 7:187–194. https://doi.org/10.1016/j.nicl.2014.12.004 CrossRefPubMed Cerami C, Della Rosa PA, Magnani G, Santangelo R, Marcone A, Cappa SF, Perani D (2015) Brain metabolic maps in mild cognitive impairment predict heterogeneity of progression to dementia. NeuroImage Clin 7:187–194. https://​doi.​org/​10.​1016/​j.​nicl.​2014.​12.​004 CrossRefPubMed

Zurück zum Zitat Cerami C, Dodich A, Lettieri G, Iannaccone S, Magnani G, Marcone A, Gianolli L, Cappa SF, Perani D (2016) Different FDG-PET metabolic patterns at single-subject level in the behavioral variant of fronto-temporal dementia. Cortex 83:101–112. https://doi.org/10.1016/j.cortex.2016.07.008 CrossRefPubMed Cerami C, Dodich A, Lettieri G, Iannaccone S, Magnani G, Marcone A, Gianolli L, Cappa SF, Perani D (2016) Different FDG-PET metabolic patterns at single-subject level in the behavioral variant of fronto-temporal dementia. Cortex 83:101–112. https://​doi.​org/​10.​1016/​j.​cortex.​2016.​07.​008 CrossRefPubMed

Zurück zum Zitat Cerami C, Dodich A, Greco L, Iannaccone S, Magnani G, Marcone A, Pelagallo E, Santangelo R, Cappa SF, Perani D (2017) The role of single-subject brain metabolic patterns in the early differential diagnosis of primary progressive aphasias and in prediction of progression to dementia. J Alzheimers Dis 55:183–197CrossRefPubMed Cerami C, Dodich A, Greco L, Iannaccone S, Magnani G, Marcone A, Pelagallo E, Santangelo R, Cappa SF, Perani D (2017) The role of single-subject brain metabolic patterns in the early differential diagnosis of primary progressive aphasias and in prediction of progression to dementia. J Alzheimers Dis 55:183–197CrossRefPubMed

Zurück zum Zitat Caminiti SP, Alongi P, Majno L, Volontè MA, Cerami C, Gianolli L, Comi G, Perani D (2017) Evaluation of an optimized [18F]fluoro-deoxy-glucose positron emission tomography voxel-wise method to early support differential diagnosis in atypical Parkinsonian disorders. Eur J Neurol 24:687–e26CrossRefPubMed Caminiti SP, Alongi P, Majno L, Volontè MA, Cerami C, Gianolli L, Comi G, Perani D (2017) Evaluation of an optimized [18F]fluoro-deoxy-glucose positron emission tomography voxel-wise method to early support differential diagnosis in atypical Parkinsonian disorders. Eur J Neurol 24:687–e26CrossRefPubMed

Zurück zum Zitat Iaccarino L, Sala A, Caminiti SP, Perani D (2017) The emerging role of PET imaging in dementia. F1000Research 6:1830CrossRefPubMedPubMedCentral Iaccarino L, Sala A, Caminiti SP, Perani D (2017) The emerging role of PET imaging in dementia. F1000Research 6:1830CrossRefPubMedPubMedCentral

Zurück zum Zitat Ratti A, Corrado L, Castellotti B et al (2012) C9ORF72 repeat expansion in a large Italian ALS cohort: evidence of a founder effect. Neurobiol Aging 33:2528–25e7CrossRefPubMed Ratti A, Corrado L, Castellotti B et al (2012) C9ORF72 repeat expansion in a large Italian ALS cohort: evidence of a founder effect. Neurobiol Aging 33:2528–25e7CrossRefPubMed

Zurück zum Zitat Varrone A, Asenbaum S, Vander Borght T, Booij J, Nobili F, Någren K, Darcourt J, Kapucu OL, Tatsch K, Bartenstein P, van Laere K, European Association of Nuclear Medicine Neuroimaging Committee (2009) EANM procedure guidelines for PET brain imaging using [18F] FDG, version 2. Eur J Nucl Med Mol Imaging 36:2103–2110. https://doi.org/10.1007/s00259-009-1264-0 CrossRef Varrone A, Asenbaum S, Vander Borght T, Booij J, Nobili F, Någren K, Darcourt J, Kapucu OL, Tatsch K, Bartenstein P, van Laere K, European Association of Nuclear Medicine Neuroimaging Committee (2009) EANM procedure guidelines for PET brain imaging using [18F] FDG, version 2. Eur J Nucl Med Mol Imaging 36:2103–2110. https://​doi.​org/​10.​1007/​s00259-009-1264-0 CrossRef

Zurück zum Zitat Della Rosa PA, Cerami C, Gallivanone F et al (2014) A standardized [18F]-FDG-PET template for spatial normalization in statistical parametric mapping of dementia. Neuroinformatics 12:575–593CrossRefPubMed Della Rosa PA, Cerami C, Gallivanone F et al (2014) A standardized [18F]-FDG-PET template for spatial normalization in statistical parametric mapping of dementia. Neuroinformatics 12:575–593CrossRefPubMed

Zurück zum Zitat Friston KJ, Holmes AP, Worsley KJ, Poline JP, Frith CD, Frackowiak RSJ (1994) Statistical parametric maps in functional imaging: a general linear approach. Hum Brain Mapp 2:189–210CrossRef Friston KJ, Holmes AP, Worsley KJ, Poline JP, Frith CD, Frackowiak RSJ (1994) Statistical parametric maps in functional imaging: a general linear approach. Hum Brain Mapp 2:189–210CrossRef

Zurück zum Zitat Cistaro A, Valentini MC, Chiò A, Nobili F, Calvo A, Moglia C, Montuschi A, Morbelli S, Salmaso D, Fania P, Carrara G, Pagani M (2012) Brain hypermetabolism in amyotrophic lateral sclerosis: a FDG PET study in ALS of spinal and bulbar onset. Eur J Nucl Med Mol Imaging 39:251–259CrossRefPubMed Cistaro A, Valentini MC, Chiò A, Nobili F, Calvo A, Moglia C, Montuschi A, Morbelli S, Salmaso D, Fania P, Carrara G, Pagani M (2012) Brain hypermetabolism in amyotrophic lateral sclerosis: a FDG PET study in ALS of spinal and bulbar onset. Eur J Nucl Med Mol Imaging 39:251–259CrossRefPubMed

Zurück zum Zitat Khan BK, Yokoyama JS, Takada LT, et al (2012) Atypical, slowly progressive behavioural variant frontotemporal dementia associated with C9ORF72 hexanucleotide expansion. https://doi.org/10.1136/jnnp-2011-301883 Khan BK, Yokoyama JS, Takada LT, et al (2012) Atypical, slowly progressive behavioural variant frontotemporal dementia associated with C9ORF72 hexanucleotide expansion. https://​doi.​org/​10.​1136/​jnnp-2011-301883

Zurück zum Zitat Ishihara K, Araki S, Ihori N, Shiota JI, Kawamura M, Nakano I (2006) An autopsy case of frontotemporal dementia with severe dysarthria and motor neuron disease showing numerous basophilic inclusions. Neuropathology 26:447–454. https://doi.org/10.1111/j.1440-1789.2006.00717.x CrossRefPubMed Ishihara K, Araki S, Ihori N, Shiota JI, Kawamura M, Nakano I (2006) An autopsy case of frontotemporal dementia with severe dysarthria and motor neuron disease showing numerous basophilic inclusions. Neuropathology 26:447–454. https://​doi.​org/​10.​1111/​j.​1440-1789.​2006.​00717.​x CrossRefPubMed

Zurück zum Zitat Strong MJ, Abrahams S, Goldstein LH et al (2017) Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria. Amyotroph Lateral Scler Front Degener. https://doi.org/10.1080/21678421.2016.1267768 Strong MJ, Abrahams S, Goldstein LH et al (2017) Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria. Amyotroph Lateral Scler Front Degener. https://​doi.​org/​10.​1080/​21678421.​2016.​1267768

Zurück zum Zitat Portet F, Cadilhac C, Touchon J, Camu W (2001) Cognitive impairment in motor neuron disease with bulbar onset. Amyotroph Lateral Scler Other Mot Neuron Disord 2:23–29. https://doi.org/10.1080/146608201300079382 CrossRef Portet F, Cadilhac C, Touchon J, Camu W (2001) Cognitive impairment in motor neuron disease with bulbar onset. Amyotroph Lateral Scler Other Mot Neuron Disord 2:23–29. https://​doi.​org/​10.​1080/​1466082013000793​82 CrossRef

Zurück zum Zitat Origone P, Accardo J, Verdiani S, Lamp M, Arnaldi D, Bellone E, Picco A, Morbelli S, Mandich P, Nobili F (2015) Neuroimaging features in C9orf72 and TARDBP double mutation with FTD phenotype. Neurocase 21:529–534CrossRefPubMed Origone P, Accardo J, Verdiani S, Lamp M, Arnaldi D, Bellone E, Picco A, Morbelli S, Mandich P, Nobili F (2015) Neuroimaging features in C9orf72 and TARDBP double mutation with FTD phenotype. Neurocase 21:529–534CrossRefPubMed

Zurück zum Zitat Levy JP, Bocti C, Elie D, et al (2018) Bifrontal hypermetabolism on brain FDG-PET in a case of C9orf72-related behavioral variant of frontotemporal dementia. J Neuropsychiatry Clin Neurosci appi-neuropsych Levy JP, Bocti C, Elie D, et al (2018) Bifrontal hypermetabolism on brain FDG-PET in a case of C9orf72-related behavioral variant of frontotemporal dementia. J Neuropsychiatry Clin Neurosci appi-neuropsych

Zurück zum Zitat Josephs KA, Whitwell JL, Knopman DS, Boeve BF, Vemuri P, Senjem ML, Parisi JE, Ivnik RJ, Dickson DW, Petersen RC, Jack CR (2009) Two distinct subtypes of right temporal variant frontotemporal dementia. Neurology 73:1443–1450. https://doi.org/10.1212/WNL.0b013e3181bf9945 CrossRefPubMedPubMedCentral Josephs KA, Whitwell JL, Knopman DS, Boeve BF, Vemuri P, Senjem ML, Parisi JE, Ivnik RJ, Dickson DW, Petersen RC, Jack CR (2009) Two distinct subtypes of right temporal variant frontotemporal dementia. Neurology 73:1443–1450. https://​doi.​org/​10.​1212/​WNL.​0b013e3181bf9945​ CrossRefPubMedPubMedCentral

Zurück zum Zitat Schroeter ML, Laird AR, Chwiesko C, Deuschl C, Schneider E, Bzdok D, Eickhoff SB, Neumann J (2014) Conceptualizing neuropsychiatric diseases with multimodal data-driven meta-analyses - the case of behavioral variant frontotemporal dementia. Cortex 57:22–37. https://doi.org/10.1016/j.cortex.2014.02.022 CrossRefPubMed Schroeter ML, Laird AR, Chwiesko C, Deuschl C, Schneider E, Bzdok D, Eickhoff SB, Neumann J (2014) Conceptualizing neuropsychiatric diseases with multimodal data-driven meta-analyses - the case of behavioral variant frontotemporal dementia. Cortex 57:22–37. https://​doi.​org/​10.​1016/​j.​cortex.​2014.​02.​022 CrossRefPubMed

Zurück zum Zitat Tan RH, Devenney E, Dobson-Stone C, Kwok JB, Hodges JR, Kiernan MC, Halliday GM, Hornberger M (2014) Cerebellar integrity in the amyotrophic lateral sclerosis - frontotemporal dementia continuum. PLoS One 9:e105632. https://doi.org/10.1371/journal.pone.0105632 CrossRefPubMedPubMedCentral Tan RH, Devenney E, Dobson-Stone C, Kwok JB, Hodges JR, Kiernan MC, Halliday GM, Hornberger M (2014) Cerebellar integrity in the amyotrophic lateral sclerosis - frontotemporal dementia continuum. PLoS One 9:e105632. https://​doi.​org/​10.​1371/​journal.​pone.​0105632 CrossRefPubMedPubMedCentral

Zurück zum Zitat Mackenzie IRA, Frick P, Neumann M (2014) The neuropathology associated with repeat expansions in the C9ORF72 gene. Acta Neuropathol 127:347–357. https://doi.org/10.1007/s00401-013-1232-4 CrossRefPubMed Mackenzie IRA, Frick P, Neumann M (2014) The neuropathology associated with repeat expansions in the C9ORF72 gene. Acta Neuropathol 127:347–357. https://​doi.​org/​10.​1007/​s00401-013-1232-4 CrossRefPubMed

Zurück zum Zitat Cooper-Knock J, Kirby J, Highley R, Shaw PJ (2015) The spectrum of C9orf72-mediated neurodegeneration and amyotrophic lateral sclerosis. Neurotherapeutics 12:326–339. https://doi.org/10.1007/s13311-015-0342-1 CrossRefPubMedPubMedCentral Cooper-Knock J, Kirby J, Highley R, Shaw PJ (2015) The spectrum of C9orf72-mediated neurodegeneration and amyotrophic lateral sclerosis. Neurotherapeutics 12:326–339. https://​doi.​org/​10.​1007/​s13311-015-0342-1 CrossRefPubMedPubMedCentral

Zurück zum Zitat Rohrer JD, Isaacs AM, Mizlienska S et al (2015) C9orf72 expansions in frontotemporal dementia and amyotrophic lateral sclerosis. Lancet Neurol 14:291–301. https://doi.org/10.1016/S1474-4422(14)70233-9 CrossRefPubMed Rohrer JD, Isaacs AM, Mizlienska S et al (2015) C9orf72 expansions in frontotemporal dementia and amyotrophic lateral sclerosis. Lancet Neurol 14:291–301. https://​doi.​org/​10.​1016/​S1474-4422(14)70233-9 CrossRefPubMed

Zurück zum Zitat Burrell JR, Halliday GM, Kril JJ, Ittner LM, Götz J, Kiernan MC, Hodges JR (2016) The frontotemporal dementia-motor neuron disease continuum. Lancet 388:919–931. https://doi.org/10.1016/S0140-6736(16)00737-6 CrossRefPubMed Burrell JR, Halliday GM, Kril JJ, Ittner LM, Götz J, Kiernan MC, Hodges JR (2016) The frontotemporal dementia-motor neuron disease continuum. Lancet 388:919–931. https://​doi.​org/​10.​1016/​S0140-6736(16)00737-6 CrossRefPubMed

Zurück zum Zitat Yokokura M, Mori N, Yagi S, Yoshikawa E, Kikuchi M, Yoshihara Y, Wakuda T, Sugihara G, Takebayashi K, Suda S, Iwata Y, Ueki T, Tsuchiya KJ, Suzuki K, Nakamura K, Ouchi Y (2011) In vivo changes in microglial activation and amyloid deposits in brain regions with hypometabolism in Alzheimer’s disease. Eur J Nucl Med Mol Imaging 38:343–351CrossRefPubMed Yokokura M, Mori N, Yagi S, Yoshikawa E, Kikuchi M, Yoshihara Y, Wakuda T, Sugihara G, Takebayashi K, Suda S, Iwata Y, Ueki T, Tsuchiya KJ, Suzuki K, Nakamura K, Ouchi Y (2011) In vivo changes in microglial activation and amyloid deposits in brain regions with hypometabolism in Alzheimer’s disease. Eur J Nucl Med Mol Imaging 38:343–351CrossRefPubMed

Zurück zum Zitat Yamanaka K, Chun SJ, Boillee S, Fujimori-Tonou N, Yamashita H, Gutmann DH, Takahashi R, Misawa H, Cleveland DW (2008) Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat Neurosci 11:251–253CrossRefPubMedPubMedCentral Yamanaka K, Chun SJ, Boillee S, Fujimori-Tonou N, Yamashita H, Gutmann DH, Takahashi R, Misawa H, Cleveland DW (2008) Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat Neurosci 11:251–253CrossRefPubMedPubMedCentral

Zurück zum Zitat Turner MR, Cagnin A, Turkheimer FE, Miller CCJ, Shaw CE, Brooks DJ, Leigh PN, Banati RB (2004) Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study. Neurobiol Dis 15:601–609CrossRefPubMed Turner MR, Cagnin A, Turkheimer FE, Miller CCJ, Shaw CE, Brooks DJ, Leigh PN, Banati RB (2004) Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study. Neurobiol Dis 15:601–609CrossRefPubMed

Zurück zum Zitat Grabert K, Michoel T, Karavolos MH et al (2016) Microglial brain region− dependent diversity and selective regional sensitivities to aging. Nat Neurosci 19:504CrossRefPubMedPubMedCentral Grabert K, Michoel T, Karavolos MH et al (2016) Microglial brain region− dependent diversity and selective regional sensitivities to aging. Nat Neurosci 19:504CrossRefPubMedPubMedCentral

Zurück zum Zitat Byrne S, Elamin M, Bede P, Shatunov A, Walsh C, Corr B, Heverin M, Jordan N, Kenna K, Lynch C, McLaughlin RL, Iyer PM, O'Brien C, Phukan J, Wynne B, Bokde AL, Bradley DG, Pender N, al-Chalabi A, Hardiman O (2012) Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study. Lancet Neurol 11:232–240. https://doi.org/10.1016/S1474-4422(12)70014-5 CrossRefPubMedPubMedCentral Byrne S, Elamin M, Bede P, Shatunov A, Walsh C, Corr B, Heverin M, Jordan N, Kenna K, Lynch C, McLaughlin RL, Iyer PM, O'Brien C, Phukan J, Wynne B, Bokde AL, Bradley DG, Pender N, al-Chalabi A, Hardiman O (2012) Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study. Lancet Neurol 11:232–240. https://​doi.​org/​10.​1016/​S1474-4422(12)70014-5 CrossRefPubMedPubMedCentral

Zurück zum Zitat Cooper-Knock J, Shaw PJ, Kirby J (2014) The widening spectrum of C9ORF72-related disease; genotype/phenotype correlations and potential modifiers of clinical phenotype. Acta Neuropathol 127:333–345. https://doi.org/10.1007/s00401-014-1251-9 CrossRefPubMedPubMedCentral Cooper-Knock J, Shaw PJ, Kirby J (2014) The widening spectrum of C9ORF72-related disease; genotype/phenotype correlations and potential modifiers of clinical phenotype. Acta Neuropathol 127:333–345. https://​doi.​org/​10.​1007/​s00401-014-1251-9 CrossRefPubMedPubMedCentral

Zurück zum Zitat Adeli A, Savica R, Lowe VJ, Vemuri P, Knopman DS, DeJesus-Hernandez M, Rademakers R, Fields JA, Crum BA, Jack CR, Petersen RC, Boeve BF (2014) The GGGGCC repeat expansion in C9ORF72 in a case with discordant clinical and FDG-PET findings: PET trumps syndrome. Neurocase 20:110–120CrossRefPubMed Adeli A, Savica R, Lowe VJ, Vemuri P, Knopman DS, DeJesus-Hernandez M, Rademakers R, Fields JA, Crum BA, Jack CR, Petersen RC, Boeve BF (2014) The GGGGCC repeat expansion in C9ORF72 in a case with discordant clinical and FDG-PET findings: PET trumps syndrome. Neurocase 20:110–120CrossRefPubMed

Zurück zum Zitat Saint-Aubert L, Sagot C, Wallon D, Hannequin D, Payoux P, Nemmi F, Bezy C, Chauveau N, Campion D, Puel M, Chollet F, Pariente J (2014) A case of logopenic primary progressive aphasia with C9ORF72 expansion and cortical florbetapir binding. J Alzheimers Dis 42:413–420CrossRefPubMed Saint-Aubert L, Sagot C, Wallon D, Hannequin D, Payoux P, Nemmi F, Bezy C, Chauveau N, Campion D, Puel M, Chollet F, Pariente J (2014) A case of logopenic primary progressive aphasia with C9ORF72 expansion and cortical florbetapir binding. J Alzheimers Dis 42:413–420CrossRefPubMed

Zurück zum Zitat Majounie E, Renton AE, Mok K, Dopper EG, Waite A, Rollinson S, Chiò A, Restagno G, Nicolaou N, Simon-Sanchez J, van Swieten J, Abramzon Y, Johnson JO, Sendtner M, Pamphlett R, Orrell RW, Mead S, Sidle KC, Houlden H, Rohrer JD, Morrison KE, Pall H, Talbot K, Ansorge O, Chromosome 9-ALS/FTD Consortium, French research network on FTLD/FTLD/ALS, ITALSGEN Consortium, Hernandez DG, Arepalli S, Sabatelli M, Mora G, Corbo M, Giannini F, Calvo A, Englund E, Borghero G, Floris GL, Remes AM, Laaksovirta H, McCluskey L, Trojanowski JQ, van Deerlin V, Schellenberg GD, Nalls MA, Drory VE, Lu CS, Yeh TH, Ishiura H, Takahashi Y, Tsuji S, le Ber I, Brice A, Drepper C, Williams N, Kirby J, Shaw P, Hardy J, Tienari PJ, Heutink P, Morris HR, Pickering-Brown S, Traynor BJ (2012) Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol 11:323–330CrossRefPubMedPubMedCentral Majounie E, Renton AE, Mok K, Dopper EG, Waite A, Rollinson S, Chiò A, Restagno G, Nicolaou N, Simon-Sanchez J, van Swieten J, Abramzon Y, Johnson JO, Sendtner M, Pamphlett R, Orrell RW, Mead S, Sidle KC, Houlden H, Rohrer JD, Morrison KE, Pall H, Talbot K, Ansorge O, Chromosome 9-ALS/FTD Consortium, French research network on FTLD/FTLD/ALS, ITALSGEN Consortium, Hernandez DG, Arepalli S, Sabatelli M, Mora G, Corbo M, Giannini F, Calvo A, Englund E, Borghero G, Floris GL, Remes AM, Laaksovirta H, McCluskey L, Trojanowski JQ, van Deerlin V, Schellenberg GD, Nalls MA, Drory VE, Lu CS, Yeh TH, Ishiura H, Takahashi Y, Tsuji S, le Ber I, Brice A, Drepper C, Williams N, Kirby J, Shaw P, Hardy J, Tienari PJ, Heutink P, Morris HR, Pickering-Brown S, Traynor BJ (2012) Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol 11:323–330CrossRefPubMedPubMedCentral

Zurück zum Zitat Martikainen MH, Gardberg M, Jansson L, Röyttä M, Rinne JO, Kaasinen V (2014) Brain 18F-FDG and 11C-PiB PET findings in two siblings with FTD/ALS associated with the C9ORF72 repeat expansion. Neurocase 20:150–157CrossRefPubMed Martikainen MH, Gardberg M, Jansson L, Röyttä M, Rinne JO, Kaasinen V (2014) Brain 18F-FDG and 11C-PiB PET findings in two siblings with FTD/ALS associated with the C9ORF72 repeat expansion. Neurocase 20:150–157CrossRefPubMed